Last update 22 Mar 2025

Fusion protein AAFP(Shanghai Kexin Biotech)

Overview

Basic Info

Drug Type
Fusion protein
Synonyms-
Target
CD32B x FCER1A
Action
modulators
Mechanism
CD32B modulators(Low affinity immunoglobulin gamma Fc region receptor II-b modulators), FCER1A modulators(IgE Fc receptor, alpha-subunit modulators), Immunomodulators
Therapeutic Areas
Immune System DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Allergic asthma
Originator Organization
Shanghai Kexin Biotech Co., Ltd.Shanghai Kexin Biotech Co., Ltd.
Active Organization-
Inactive Organization
Shanghai Kexin Biotech Co., Ltd.Shanghai Kexin Biotech Co., Ltd.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Fusion protein AAFP(Shanghai Kexin Biotech)
CTR20182103
/ CompletedPhase 1
重组人免疫球蛋白ε和γ的Fc融合蛋白注射液健康人体皮肤试验
[Translation] Skin test of recombinant human immunoglobulin ε and γ Fc fusion protein injection in healthy human body
100 Clinical Results associated with Fusion protein AAFP(Shanghai Kexin Biotech)
Login to view more data
100 Translational Medicine associated with Fusion protein AAFP(Shanghai Kexin Biotech)
Login to view more data
100 Patents (Medical) associated with Fusion protein AAFP(Shanghai Kexin Biotech)
Login to view more data
100 Deals associated with Fusion protein AAFP(Shanghai Kexin Biotech)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Allergic asthmaPhase 1
China
Shanghai Kexin Biotech Co., Ltd.Shanghai Kexin Biotech Co., Ltd.
26 Nov 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free